u/annika_fonseca

Strength retention is an imperfect but free longitudinal proxy: it is affected by neural factors and by being in a deficit, so it tracks tissue change loosely rather than exactly.

Cosigning on keeping the hash. It is the only receipt in existence and people screenshot their balance instead.

Yes — the same token symbol on two chains catches people constantly and it is unrecoverable.

Asked which networks SGN accepted before ordering and picked the cheapest one at that hour. Saved more than the difference in price.

dose response is not linear and nobody should assume it is

Not convinced by the linearity assumption. Dose-response in this class is not linear and the trials show it.

Right — strength retention is a free proxy and it tracks better than most people expect.

DEXA has a real error margin and people quote it to one decimal

That figure is from the obesity programme, and this thread is about the hepatic one.

Have the lifts held, dropped, or moved around?

It is a dual agonist at the GLP-1 and glucagon receptors. The glucagon arm is associated with increased energy expenditure and with effects on hepatic fat, which is why the development programme is oriented towards liver disease.

dose response is not linear and nobody should assume it is

How long was the randomised phase before any extension?

regional stock changes everything about transit

I would not treat a delayed confirmation as evidence of anything at all. Chains have busy hours.

Yes — median rather than best case. The fastest anybody ever got is not a plan.

Receptor expression in a tissue is necessary but not sufficient for an effect. You also need the agonist to reach it at relevant exposure, and that is where a lot of confident mechanism talk falls down.

How many confirmations does it show?

I would not treat a delayed confirmation as evidence of anything at all. Chains have busy hours.

Pasted rather than typed the address, then checked the first and last six characters. Habit now.

keep the hash, it is the only receipt that exists

Is there any human data on that mechanism yet?

Posted my first lane report here without the month and got asked for it. Fair, and the table is better for the fussiness.

The transaction hash is the canonical receipt: it is public, verifiable by either party, and it is what a support query should quote.

Origin, destination, carrier and month?

Agreed that quote expiry is ordinary. Rates move and a time-limited quote is not a pressure tactic on its own.

Agreed — and the hash is the receipt.

Adding the cheap insurance — test amount first on anything large.

The registered protocol is public. Comparing the registered primary endpoint with the reported one is a two-minute check and it is how outcome switching gets caught.

Yes — nothing containing this is approved anywhere, which is the first fact and usually the last one mentioned.

Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use.

That conflates receptor affinity with clinical potency. They are related and they are not the same thing.

How long was the randomised phase before any extension?

What was the exposure in that experiment relative to therapeutic?

Total transit decomposes into first mile, international leg, clearance and last mile. Only the first two are meaningfully under the shipper’s control and most reported variance sits in the last two.

the last mile is where most of the variance lives

Same. TFC quoted 6 days on my lane and it landed at 14, which is exactly what you want from a quote.

Long half-life in this class comes from structural modification that promotes albumin binding and resists enzymatic degradation. Weekly dosing is a consequence of the molecule, not a convenience decision.